Literature DB >> 17707279

Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks.

William Parker1, Edith Filion, David Roberge, Carolyn R Freeman.   

Abstract

PURPOSE: To report the results of an analysis of dose received to tissues and organs outside the target volume, in the setting of spinal axis irradiation for the treatment of medulloblastoma, using three treatment techniques. METHODS AND MATERIALS: Treatment plans (total dose, 23.4 Gy) for a standard two-dimensional (2D) technique, a three-dimensional (3D) technique using a 3D imaging-based target volume, and an intensity-modulated radiotherapy (IMRT) technique, were compared for 3 patients in terms of dose-volume statistics for target coverage, as well as organ at risk (OAR) and overall tissue sparing.
RESULTS: Planning target volume coverage and dose homogeneity was superior for the IMRT plans for V(95%) (IMRT, 100%; 3D, 96%; 2D, 98%) and V(107%) (IMRT, 3%; 3D, 38%; 2D, 37%). In terms of OAR sparing, the IMRT plan was better for all organs and whole-body contour when comparing V(10Gy), V(15Gy), and V(20Gy). The 3D plan was superior for V(5Gy) and below. For the heart and liver in particular, the IMRT plans provided considerable sparing in terms of V(10Gy) and above. In terms of the integral dose, the IMRT plans were superior for liver (IMRT, 21.9 J; 3D, 28.6 J; 2D, 38.6 J) and heart (IMRT, 9 J; 3D, 14.1J; 2D, 19.4 J), the 3D plan for the body contour (IMRT, 349 J; 3D, 337 J; 2D, 555 J).
CONCLUSIONS: Intensity-modulated radiotherapy is a valid treatment option for spinal axis irradiation. We have shown that IMRT results in sparing of organs at risk without a significant increase in integral dose.

Entities:  

Mesh:

Year:  2007        PMID: 17707279     DOI: 10.1016/j.ijrobp.2007.04.052

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost.

Authors:  M Foote; B-A Millar; A Sahgal; C Ménard; D Payne; W Mason; N Laperriere
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

2.  High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy.

Authors:  D S Sharma; T Gupta; R Jalali; Z Master; R D Phurailatpam; R Sarin
Journal:  Br J Radiol       Date:  2009-07-06       Impact factor: 3.039

3.  Reducing the dosimetric impact of positional errors in field junctions for craniospinal irradiation using VMAT.

Authors:  Andrej Strojnik; Ignasi Méndez; Primož Peterlin
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-28

4.  Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.

Authors:  Chi Lin; Sarah S Donaldson; Jane L Meza; James R Anderson; Elizabeth R Lyden; Christopher K Brown; Karen Morano; Fran Laurie; Carola A Arndt; Charles A Enke; John C Breneman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-04       Impact factor: 7.038

Review 5.  Medulloblastoma.

Authors:  Nathan E Millard; Kevin C De Braganca
Journal:  J Child Neurol       Date:  2015-09-02       Impact factor: 1.987

6.  The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation.

Authors:  A Pérez-Andújar; W D Newhauser; P J Taddei; A Mahajan; R M Howell
Journal:  Phys Med Biol       Date:  2013-04-19       Impact factor: 3.609

7.  Craniospinal radiotherapy in children: Electron- or photon-based technique of spinal irradiation.

Authors:  Marzanna Chojnacka; Anna Skowrońska-Gardas; Marzena Morawska-Kaczyńska; Anna Zygmuntowicz-Piętka; Katarzyna Pędziwiatr; Anna Semaniak
Journal:  Rep Pract Oncol Radiother       Date:  2010-02-18

8.  Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment.

Authors:  Pei-Ju Chao; I-Hsing Tsai; Chun-Chieh Huang; Chih-Hsueh Lin; Chin-Shiuh Shieh; Yang-Wei Hsieh; Pei-Ying Yang; Hsiao-Fei Lee; Tsair-Fwu Lee
Journal:  Front Bioeng Biotechnol       Date:  2020-05-07

Review 9.  Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature.

Authors:  Florian Sterzing; Eva M Stoiber; Simeon Nill; Harald Bauer; Peter Huber; Jürgen Debus; Marc W Münter
Journal:  Radiat Oncol       Date:  2009-09-23       Impact factor: 3.481

10.  Use of flattening filter-free photon beams in treating medulloblastoma: a dosimetric evaluation.

Authors:  Pichandi Anchineyan; Ganesh K Mani; Jerrin Amalraj; Balaji Karthik; Surega Anbumani
Journal:  ISRN Oncol       Date:  2014-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.